Forza Capital

SMARTER. FASTER. FORZA.

Request for Startups

The list of projects is updated frequently.

Funds see the wide picture — a view of the entire market — while founders see deep but narrow. Usually they don’t step beyond a single vertical: the one they studied or worked in at their previous job. As a result, potentially strong founders walk past huge markets and build services for 100 users, losing years of their lives.

RFS helps founders

  • Improve their odds of building a truly large business.
  • Secure financing — no need to write to 200 funds if there are 2 strongly interested ones.
  • Get strong feedback — such a fund has deep expertise in this specific area, and it’s probably worth listening.

The fund is interested in

  • Receiving 50 targeted pitches instead of 500 random ones.
  • Talking to strong “builders” rather than professional “pitchers” with polished slides.
  • Not buying a “lottery ticket” or “index of the entire market,” but focusing on target verticals.

Forza is highly likely to invest in these projects, provided the team and execution plan are strong.

01Home bloodwork OS. Subscription + logistics + interpretation of test results + automated correction protocols (iron, B12, inflammation, lipids) under physician supervision. Unclear how to maintain high margin with (a) home visits (especially if patients have to wait 2 hours for IV drips), (b) operating under someone else’s license. California at the start.

02Early cancer detection. Subscription business model. A service that combines multi-cancer screening (blood/tests/imaging), reminders, and navigation through diagnostics. Unclear how to solve the false-positive problem — a service that produces 10 false positives per nurse visit and scares patients to death is not viable. Quite possibly, the problem cannot be solved without technology breakthroughs. California at the start.

03Hormone optimization platform. A transparent, medically valid platform for hormonal health (men/women) where the result is measured by objective markers. Evidence-based medicine, no charlatanism. The challenge: how to keep high margin while operating under a lead-generation model (without a license)? We assume the service will start “giving advice,” which requires obtaining a license (how would you get it fast/cheaply?). California at the start.

04Geo-arbitrage in expensive medical procedures. The difficulty isn’t in the products — there are dozens of procedures where the price gap between the US and Europe/Mexico is $30K+. The hard part is finding enough customers willing to pay: people who are not rich enough to ignore the price difference, but rich enough to pay without insurance. The second problem — advertising restrictions. US only.

05AI talent scout (next-gen recruiting). Not “resume matching,” but an agent that searches for people everywhere, evaluates real skills, writes to them, runs the conversation, and closes the hire. There are already many alternatives — what makes this one better? The task is hard, but we’re fighting for a high check (one annual salary of the candidate, ~$80K per client). US only.

06Digital copy of a person. Not just preserving information (correspondence, video, interviews, transcripts of every conversation). Not just chat/video you can talk to. The next level.

07Family offices. Solutions for UHNWI managers. The value should be measured in millions of dollars, not “slides got prettier and faster to make.”

We’re looking for EIRs

Venture funds expect an EIR to launch a project the fund will finance within 3–9 months. Often, the idea is unknown at the start, and the EIR spends a lot of time researching adjacent markets, talking to operators, and stress-testing hypotheses before committing.

What an EIR does

01

Launches new projects.

02

Brings strong deal flow.

What sets a strong EIR apart

  1. A self-guided missile — receives a problem and brings back a solution, not 8 excuses.
  2. Power of persuasion — convinces a co-founder to leave the corporate world, a customer to buy something that exists only as a prototype, and an investor to write a check.
  3. Despite his experience, still does a lot of hands-on work — dives into details, micromanages aggressively at the start.
  4. A fast-iteration machine — tests hypotheses quickly, comes up with 5 new ones even faster after the failed ones.
  5. Strong track record of success — a variety of achievements in early-stage startup projects.

Why an EIR role is worth it

  1. Sign your first investor for your future startup.
  2. Get a feel for the market — a lot has changed in other industries while you ran your last project. Funds see a wide cross-section. See the latest trends.
  3. Spend 6–9 months experimenting with different startup ideas while hunting for a unicorn.

If this sounds interesting, contact us.

Forza Capital family office invests in:

01AI & biotech VC funds as LP.
02Radical longevity.
— Partial cellular reprogramming with a realistic path to in vivo therapies.
— Organ-on-a-chip systems.
— In vivo delivery platforms for epigenetic or gene-editing longevity therapies.
— Blood and plasma-derived therapies with rigorous clinical endpoints beyond “feeling better”.
— Organ-scale replacement technologies that can integrate into existing surgical workflows.
03Constrained-supply real estate.
04Asset-backed lending with transparent collateral coverage.
05Special situations in private markets (restructurings, secondary stakes, liquidity for founders).
06Opportunistic public markets in our focus areas.

Forza Capital family office invests in:

01AI & biotech VC funds as LP.
02Radical longevity.
— Partial cellular reprogramming with a realistic path to in vivo therapies.
— Organ-on-a-chip systems.
— In vivo delivery platforms for epigenetic or gene-editing longevity therapies.
— Blood and plasma-derived therapies with rigorous clinical endpoints beyond “feeling better”.
— Organ-scale replacement technologies that can integrate into existing surgical workflows.
03Constrained-supply real estate.
04Asset-backed lending with transparent collateral coverage.
05Special situations in private markets (restructurings, secondary stakes, liquidity for founders).
06Opportunistic public markets in our focus areas.